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Introduction: Surgically treatable conditions represent about 11 % of the world’s Disability 
Adjusted Life Years (DALYs) lost. Cost-effectiveness analyses for trauma show that surgical 
interventions are more cost effective as compared to non-surgical interventions. The objective of 
this study is to do a health economic evaluation of orthopedic treatment of femur bone fracture 
by comparing traction and Intramedullary Nail (IMN) for patients treated at a tertiary and general 
hospitals in Addis Ababa, Ethiopia. 
Method: Direct out of pocket expenditures that were included are cost of hospitals bed day, 
drugs, investigations and physiotherapy. Patients’ medical record was used to extract the type 
and number of investigations ordered and medications given. Expenditures were estimated by 
multiplying the number of investigations and medicines reported by each patient by their prices 
as given by the price-list of service fees set by the hospitals. The unit cost of health worker per 
treated patient was calculated by multiplying the time spent to treat a patient by salary rate per 
hour of health professionals. Patients were interviewed about their functional status using a 
structured questionnaire. Their health status was then used to select disability weights as given 
by the Global Burden of Disease Study, and further used to estimate health outcomes as Health 
Adjusted Life Years (HALY). A societal cost perspective has been used, and health benefits 
were calculated over a lifetime.  
Results: The direct out of pocket expenditure for the traction treatment group was 6,262 USD 
(132,754 ETB). Cost per patient is 250 USD (5,310 ETB). Provider costs for the traction 
treatment group was 1,562 USD (33,114 ETB) and total cost was 7824 USD (165,869 ETB). The 
direct out of pocket expenditure for the IMN treatment group was 4,849 USD (102,804 ETB). 
Cost per patient was 194 USD (4,112 ETB).  Provider costs for the IMN treatment group was   
6,112 USD (129,574 ETB) and total costs was 10,961 USD (232,373 ETB).  
The net discounted HALY gained in the traction treatment group was 16.2 and the net discounted 
HALY gained in the IMN group was 33.6.  The average cost-effectiveness ratio (ACER) for the 




USD/HALY gained. Therefor the incremental cost of going from traction to IMN treatment 
group was 3,137 USD and the incremental health gain was 17 HALYs. The incremental cost-
effectiveness ratio was 180 USD per HALY gained.   
Conclusion: This study has shown that IMN is more cost effective than traction for the treatment 
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ACER – Average Cost-Effectiveness Ratio  
CEA – Cost-Effectiveness Analysis  
DALY – Disability Adjusted Life Years  
ETB – Ethiopian Birr  
GBD – Global Burden of Disease 
HALY – Health Adjusted Life Year  
HIC – High Income Countries 
IM- Intra Medullary  
ICER – Incremental Cost-effectiveness Ratio  
LMIC – Low and Middle Income Countries  









First and for most, I would like to express my deepest gratitude to my supervisors Kjell Arne 
Johansson and Ole Frithjof Norheim for their unreserved support to provide valuable comments, 
suggestions and guiding ideas from the initiation to the end of this research, and to Stéphane 
Verguet for his advice - I would also like to thank Yonatan Desalegn, Mengistu Gebreyohanes 
and Mitslal Kidane for the expert opinion they have provided me.  
I would also like to thank Ministry of Health of Ethiopia and the project “Priorities 2020” at the 
Research group of Global Health Priorities at the University of Bergen for giving me the 
opportunity to be part of the master’s program at Centre for International Health at the 
University of Bergen. I would like to thank staffs and members of Center for International Health 
for their support. 
I would like to extend my special thanks to my data collectors and study participants for their 
willingness to participate in the study.  
Finally, I would like to take this opportunity to thank my family and friends for their support and 















1.1 Background  
        
Conditions that are treated primarily or frequently by surgery constitute a significant portion of 
the global burden of disease. The significant avertable burden from surgical conditions is directly 
related  to the low capacity for surgical care in many low and middle income countries LMIC(1). 
Surgically treatable conditions represent about 11 % of the world’s Disability Adjusted Life 
Years (DALYs) lost, which is about equivalent to the number of DALYs contributed by 
HIV/AIDS, malaria and tuberculosis combined (2).    
LMIC experience more than 91% (5.3 million) of injury-related deaths in the world according to 
a study by Sharma et al (3). Injuries often result in long-term disability. For every person who 
dies from injury, many more are injured, with temporary or permanent disability (4).   
Ethiopia, is one of the most populous nations in the Sub Saharan African continent. The 
population was estimated to be 96.96 million in 2014 with life expectancy of 63 years at time of 
birth (5). The burden of injury is high in Ethiopia. For instance in the 2013 – 2014 Ethiopian 
Fiscal Year trauma including fracture of the extremities was the fourth leading cause of 
admission in Ethiopian hospitals (6). Road traffic accident is the cause of such injuries in most 
cases (7-9).  
A three year retrospective study on orthopedic and major limb trauma in Tikur Anbessa 
Specialized Hospital showed that 49.7% of all patients admitted at the orthopedic ward had 
upper limb injury and 43.5% had lower limb injury. The leg (below knee) was the most common 
limb site injured (22.2%) (10). A similar study done in Dilchora Refferal hospital, located in 
Eastern Part of Ethiopia also showed that patients with long bone injury of the lower extremity 
constituted up to 73 % of all patients admitted to orthopedic ward (11). The femur is the largest 
bone of the body and principal weight bearing bone of the lower extremity that is commonly 




A study done in Ghana has shown that the prevalence of long term injury related disability was 
0.83% (95% CI: 0.67%, 1.00%) in the population surveyed and 78% of such disabilities were 
due to extremity injuries (13). Most fractures result in a temporary loss of function for the patient 
and also a loss of work time for the parents, children or other careers of the injured person (11).      
 
1.2 Statement of the Problem  
        
There are different treatment options for fractures. In general, fractures are managed by closed or 
open reduction depending on the type and severity of the fracture. Closed reduction include 
casting and traction and those under open reduction include external and internal fixation. (4)  
Traction refers to the set of mechanisms for straightening broken bones or relieving pressure on 
the spine and skeletal system. There are two types of traction, skin traction and skeletal traction. 
Skeletal traction is applied to the affected structure by a metal pin or wire inserted into the 
structure and attached to traction ropes. Skeletal traction is often used when continuous traction 
is desired to immobilize, position and align a fractured bone properly during the healing 
process(14). Skin traction is a traction on an extremity by means of adhesive tape or other types 
of strapping applied to the limb having the same objective as stated for skeletal traction.  
Internal fixation involves the implementation of implants to guide the healing process of a bone, 
as well as the open reduction of the bone itself. Fixation of tibia, femur and humerus are made 
with screws and/or plates or intramedullary bone nails to enable or facilitate healing(14).  
In Ethiopia patients with femoral fracture are in  most cases treated with either skeletal or skin 
traction (8, 11, 15).The duration of hospital stay for patients managed with this treatment option 
usually takes a number of weeks (7, 12, 15). Despite long hospital stays,  results are good for 
most of the fracture patients treated by conservative management (11). Some studies have shown 
that for femur  fracture, skeletal traction remain to be safe, effective and cheap in a setting like 
Ethiopia (7).   
However, as a result of long hospital stays, new patients with similar injuries that require 




Ethiopia has shown that 69% of emergency patients requiring urgent admission had in practice 
been referred to other hospitals (10). Furthermore, delayed mobilization and long hospital stays 
can have a significant economic impact on patients, their families and more broadly on the 
hospital and health care system (15).  
Surgical treatment for fracture of hip, femur and tibia have been found to be superior over 
conservative management in high income countries (HIC). However, to this day, most of these 
fractures are treated conservatively with cast or traction in LMICs (8). It has been a long 
standing dogma that surgery for musculoskeletal (MSK) injuries would be too expensive in 
LMIC (17).  
 
2. OBJECTIVES  
 General Objective  
Ø Perform a health economic evaluation of orthopedic treatment of femur bone fracture by 
comparing traction and Intramedullary Nail (IMN) for patients treated at a tertiary and 
general hospitals in Addis Ababa.   
Specific Objective  
Ø Determine the cost for femur bone fracture treatment by traction for patients treated in 
Addis Ababa Burn Emergency Medicine and Trauma Hospital (AaBET) and Menelik 
Hospital in April and May, 2016.   
Ø Determine the cost for femur bone fracture treatment by IMN  
Ø Calculate the Health-Adjusted Life Years (HALYs) gained for patients with femur 
fracture treated by traction   
Ø Calculate the HALYs gained for patients with femur fracture treated by IMN   
Ø Determine the cost per HALY averted for femur bone fracture treatment by traction and 
IMN treatment.          
 





3. Literature Review  
 
There have been different perspectives and recommendations with regards to management of 
femoral shaft fractures in resource poor settings. On one hand there is a group of clinical 
practitioners who argue that conservative management remains the best and very often the only 
option for femoral bone fracture. One reason is that the surgical environment is unreliable and 
this could increase the risk of surgical complications(7). However, studies done in LMIC on the 
risk of infection after IMN have shown that the infection rate was acceptable and that IM nailing 
is a safe procedure in these settings (18, 19). A systematic review by Kramer et al has shown that 
the use of traction in treating femoral shaft fractures is associated with a high incidence of 
complications and prolonged course of treatment (15).   
The other argument against surgical treatment is that surgical treatment in resource limited 
countries is relatively more costly than traction (7). However, selected surgical interventions for 
trauma have proven cost effective in these settings and innovative low cost programs and 
interventions have improved trauma care outcomes at individual hospitals (17).  
A health economic evaluation done by Gosselin et al of  Surgical Trauma Centers in Nigeria and 
Haiti estimated the cost to be  $172 and $223 per Disability-Adjusted Life Year (DALY) averted, 
which was in line with other reported Cost-Effectiveness Analyses (CEAs) of surgical and 
nonsurgical activities in similar contexts (20). Similarly in Cambodia, a study comparing the first 
50 patients who received IMN for their femur fractures to the last 50 patients who were treated 
by traction showed that surgery had better clinical outcomes and was more cost effective than 
traction (US $888 verses US $1,107 per DALY averted, respectively) (21). In  Kenya , a study 
done at  level 5 hospital found that better clinical outcome was attained at a lower cost with 
surgery compared to Perkins traction in the management of adult femoral shaft fractures. 
Majority of the patients (55.1 %) who underwent surgery attained normal mobility without any 
support compared to 29.1 % in the group managed by traction (OR 3.8 and p 0.004). The average 
cost of treatment for patients who underwent surgery was 112 USD compared to those managed 




Patients managed with skeletal or skin traction have longer hospital stays. The systematic review 
by Kramer et al showed that mean length of hospital stay for patients with femoral fracture 
treated with skeletal traction was 55.4 days (15). Long hospital stays will lead patients to incur 
more cost. This can be either direct medical cost or indirect cost associated with productivity 
loss. Patients treated with intramedullary nail have short duration of hospital stay and thus have 
less private expenditure (12).  
 
4. Justification and Significance of the Study  
 
The prevalence of injuries and fracture of extremities is increasing in Ethiopia. Despite the 
argument that surgical care for trauma patients is very expensive in resource limited countries 
like Ethiopia, there are a number of reasons to consider surgery to be one of the best treatment 
options. The first being that IMN has shown to be cost effective to similar settings like Ethiopia. 
This is so because patients that receive conservative treatment (traction) are forced to stay in 
hospitals for a long period of time, which cause additional costs to the patients (i.e. hospital bed 
and food expenditures) (20). Long hospital stays is likely to cause substantial productivity losses 
both for the patient as well as attendants. Moreover, traction patients are bed blockers. Other 
patients who could have used the same bed will be forced to wait or go elsewhere when a 
traction patient blocks the bed for a long time. This may be inefficient use of limited resources, 
including specialists. On the other hand, patients treated surgically will be discharged earlier and 
may have less productive loss and block less hospital beds. 
In a country where a significant proportion of the population live on manual work like 
agriculture, injury to upper and lower limb results in significant negative impact on productivity 
loss. Thus, it is worth to investigate if surgery is more cost-effective than traction for treatment 
of femur fractures in Ethiopia.  To the best of the investigators’ knowledge, no cost-effectiveness 
analysis of surgical treatment of femur fracture has been done in Ethiopia. Therefor by 
identifying this gap, this study is set out to explore cost effective options for femur fracture 







5.1  Study Area  
The study has been conducted in Menelik and Addis Ababa Burn Emergency Medicine and 
Trauma Hospital (AaBET). These hospitals are among the 11 government hospitals in Addis 
Ababa.  
Menelik hospital is among the early established hospitals in Addis Ababa. According to the 2016 
Health Service Directory of Ministry of Health, it has a total of 203 beds.  It gives a total of 10 
in-patient specialty services including Orthopedics. The orthopedics out patient service works 
four days in a week.  
AaBET is one of the semi-independent institutions under St Paul’s Hospital Millennium Medical 
College. AaBET provides comprehensive emergency care in emergency medicine, critical care, 
orthopedics, neurosurgery and forensic medical service.  
5.2  Study Period  
     The data has been collected from October 2016 to January 2017.   
5.3  Data Collection     
Four nurses who have experience working in hospital have been recruited to do the data 
collection. Data collectors retrieved price of drugs, physiotherapy, laboratory and imaging from 
the hospitals’ pharmacy, rehabilitation, laboratory and imaging units respectively. Salary of 
health professionals working in orthopedics ward have been retrieved from human resource 
office. Cost pertaining to medical equipment and supplies have been retrieved from pharmacy 
units.  
Disability status of patients was assessed using a questionnaire that was developed based on 
GBD 2013 description of health states. The questionnaire asks the functional status including 
walking, running and lifting heavy things. Data from patient records including type of 






5.4  Source and study Population  
5.4.1 Source Population  
Ø All patients admitted to tertiary level and general hospitals in Addis Ababa for 
femoral bone fracture treatment.  
5.4.2 Study Population   
Ø All patients admitted to Menelik and AaBET hospitals for femoral bone fracture 
during the data collection period.  
5.5   Inclusion and Exclusion Criteria  
5.5.1 Inclusion Criteria 
Ø  Patients 18 years and above with closed fracture of femur bone.   
 
 5.5.2  Exclusion Criteria  
Ø Patients diagnosed to have pathological fractures based on history and radiological 
findings.  
Ø Patients with compound fracture of the femur bone  
Ø Patients presented with poly-trauma  
  
5.6   Sampling procedure    
All patients who were treated either with IMN or skeletal traction for femur fracture in the 
months of April and May, 2016 in Menelik and AaBET hospital and who fulfilled the inclusion 
criteria were included as study participants.   
In AaBET hospital, data collectors went to orthopedics out-patient clinic. After getting written 
consent, they interviewed patients with femur fracture who were on follow up.  Similarly, data 
collectors went to Menelik hospital and interviewed 11 patients at follow up clinic but could not 
get other patients who fulfilled inclusion criteria. To identify further patients for inclusion, 
addresses of 14 patients was retrieved from the log book and from the record room. A call was 
made and consent was obtained. A data collector and the primary investigator went to their home 




5.7 Socio - demographics  
A total of 50 patients were interviewed. The mean age of patients in the traction treatment group 
is 35 with 95 % CI of (30.5, 40.2) and that in IMN group is 31 with 95 CI of (27.2, 35.37).   
 
Table 1 : Socio- demographics of study participants   
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n = 21 
n = 29 
n = 0 
n = 0 
 
8 (32 %) 




13 (52 %) 
12 (48 %) 
0 (0%) 
0 (0 %) 
Place of Residence  
Addis Ababa  
Outside Addis Ababa  
 
n = 26 















n = 6 
n = 12 
n = 24 
n = 7 
n = 1 
 
 
5 (20 %) 









2 (8 %) 
0 (0%) 
Occupation  
Employed at Gov/Priv 
Institution  
Self Employed  
Farmer  
 
n = 25 
 
n = 12 















Did not have Job  
n = 3 
n = 3 
0 
3 (12 %) 
 
 
3 (12 %) 
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5.8 Study Perspective, discounting and currency  
The chosen study perspective is a societal perspective. All costs are included regardless of who 
pays them. Resources used or created by health interventions are valued as benefits foregone 
because society could not use the resources in their next best use (22). A discount rate of 3 
percent has been used for measure of health outcome. Discount rate has not been used for cost as 
the cost that was taken is incurred in the same time period.  
The costs and effects have been analyzed using Excel 2013.  The currency Ethiopian Birr (ETB) 
has been used and then converted to USD according to the average exchange rate during the 
study period. 1 USD was on average 21.2 ETB between October 2014 and October 2016.    
5.9   Comparators  
The major treatment options are conservative management versus surgical management for 
fracture of the femur. From the conservative management, skeletal traction was selected because 
it is the most common conservative management option for fracture admitted patients. From 
surgery, IMN was selected because this treatment modality is often chosen in other countries, but 
not regarded as cost-effective in Ethiopia.   
5.10 Estimation of Health Outcomes  
Health-Adjusted Life Years (HALY) has been used as the measure of health outcome. The 
disability weight for the functional status of patients was based on the 2013 Global Burden of 
Disease study. According to the study, musculoskeletal problems has been classified as mild, 
moderate and severe with disability weight of 0.023, 0.079 and 0.165 respectively (see Annex 1). 
The questionnaire for the assessment of disability weight for femur fracture treatment was 
developed based on GBD 2013 descriptions of health states for musculoskeletal problems. For 
each question three alternative answers are provided (i.e occurs sometimes, occurs often, occurs 




states. It is assumed that patients who have mild pain will ‘sometimes’ have pain. Patients who 
have moderate pain have pain that ‘occurs often’ and patients who have severe pain have pain 
which ‘occurs almost every time’.   
For each alternative, a score is given. (i.e. ‘sometimes’- 0, ‘occurs often’ – 1, ‘occurs almost 
every time’ – 2.).Then at the end, for patients in which the sum was between 0 to 3, they have 
been categorized as having mild musculoskeletal problem, for patients having a score between 4 
up to 9, they have been categorized as having moderate musculoskeletal problem and for patients 
for which the score was between 10 to16, they have been categorized as having severe 
musculoskeletal problem.            
Once patients have been categorized using the scoring system specified above, a life table with 
GBD 2013 data on age specific mortality rates and health state valuations adjusted by the 
empirical disability weights reported by patients was used to calculate HALYs for each patient. 
A mean age of 33 was used for both groups to avoid a bias in different starting ages. Then the 
HALY gained for each of the two treatment groups was estimated.  
In order to understand the health gain from the two treatment groups better, a comparative group 
was assumed to exist for which no intervention was made.  Since there has not been any studies 
done on the disability status of un treated patients (to the best of the investigator’s knowledge), 
an assumption was made that all patients who did not get a treatment would have the same 
disability weight as patients who were categorized as having severe musculoskeletal problem. 
Discounted values of HALY were used for both treated and untreated groups. Then the net 
discounted HALY gained for the traction and the IMN group was calculated by subtracting the 
HALY gained of the untreated group from HALY gained in the treated group.   
The definition given for the different status of musculoskeletal problems in GBD 2013 are as 
follows:  
Mild Musculoskeletal problem – when the patient has pain on the leg which causes some 




Moderate musculoskeletal problem – when the patient has moderate pain in the leg which makes 
the person limp and cause some difficulty in walking, standing, lifting and carrying heavy things, 
getting up and down and sleeping. 
Severe musculoskeletal problem – when the patient has severe pain in the leg which makes the 
person limp and cause a lot of difficulty in walking, standing, lifting and carrying heavy things, 
getting up and down and sleeping.  
 
5.11 Estimation of resources and cost  
5.11.1 Provider Cost  
Salary of health professionals and cost of equipment that was used separately by the two 
treatment groups were taken as provider cost. However fixed costs like land and infrastructure 
were not taken because these utilities are being utilized by both treatment groups equally.  
 
5.11.1.1  Salary of health professionals  
The first step in estimating the salary of health professionals was to calculate the time spent for 
treating each patient at emergency outpatient unit, ward and OR by different type of health 
professionals. This was then multiplied by the salary per hour rate of the health professionals to 
get the total salary cost the hospital will incur to treat a single patient.  
Uniform hospital duration was taken for patients in the two groups to make the process of 
calculating salary cost convenient. This was done by taking the mean hospital stay i.e 53.04 days 
≈ 8 weeks for patients in traction treatment group and 36.28 days ≈ 5 weeks for patients in IMN 
treatment group. Thus, for a patient in the traction treatment group the salary cost of health 
professionals is 40 USD (845 ETB) and for a patient in IMN group it is 32 USD (679 ETB).  
5.11.1.2 Equipment  
The cost of Intramedullary nail and consumables need for procedures was included as part of the 
provider cost. Currently intramedullary nails are being provided by SIGN Fracture Care 
International which donates Intramedullary nails for low and middle income countries. The cost 
for a single SIGN nail is estimated to be 150 USD (3450 USD).  And the hospitals cover the cost 




5.11.2 Direct out of pocket expenditure  
In this study, the direct out of pocket expenditure that were included are the cost of hospitals bed 
day, drugs, investigations and physiotherapy. Data retrieved from patients’ medical record has 
been used to know the type and number of investigations ordered as well as the medications 
given during admission and follow up.    
5.11.2.1 Drug Cost  
The retail price per tablet/capsule/bottle was retrieved from the hospitals’ pharmacy units.  For 
each drug average cost was made from the two hospitals price list. This was multiplied by the 
number of frequency (number in a day and total number of days) the patient has taken the drug to 
get the total cost that the patient has incurred for medication. (See annex 2.1)    
5.11.2.2 Hospital bed day, Imaging and Laboratory  
The two hospitals have a price list for imaging, laboratory and hospital bed. Similar to drug cost 
average price-lists are available for these service fees. These were used to calculate the cost for 
each patient based on the type and number of investigations ordered and based on the total 
number of days the patient has been admitted (See annex 2.2 and 2.3).  
5.11.2.3 Physiotherapy  
Uniform follow up period has been taken to calculate service fee for physiotherapy. Based on 
expert opinion, the average duration of follow up for femur fracture patients being treated by 
traction is 3 months and that for IMN group is 2 months.   
The average service fee for physiotherapy in the two hospitals is 16 Birr/session.  A patient is 
appointed 3 times per week which will be a total of 36 visit for patients in traction treatment 
group and 24 times for patients in the IMN treatment group. This will then give 27 USD (576 
ETB) for traction group and 18 USD (384 ETB) for IMN group.  
5.12	Data	Quality	Assurance		
To ensure quality of data, data collectors was given one day orientation on how to fill the 
structured questionnaire. During the data collection period, the principal investigator had a 
session with the data collectors. During the sessions, thorough checking of the filled 




5.13 Analysis  
A decision tree model in Excel was used to calculate cost-effectiveness. The structure of the 
model is represented in Figure 1. For each patient, the cost of hospital bed day, card (registration 
payment), drug, physiotherapy, x ray, food, laboratory and attendant was arranged in a row on 
Excel 2013. The sum of each of the listed items was calculated to get the total cost a single 
patient has incurred for admission and follow up. Then these sub totals were summed up to get 
the total patient cost for the treatment group. Mean, SD, and 95 % CI were calculated to get the 
cost incurred in USD per patient. A life table with GBD 2013 data on age specific mortality rates 
and health state valuations adjusted by the empirical disability weights reported by patients was 
used to calculate HALYs for each patient. A mean age of 33 was used for both groups to avoid 
bias in different starting ages. Then the HALY gained for each of the two treatment groups was 
estimated ( See Figure 1 and more below).   
The cost of an intervention was divided to effectiveness to get the cost in USD per HALY.  The 
incremental cost-effectiveness ratio was calculated as: 
            =    Cost IMN – Cost traction   / HALY IMN – HALY traction 





                     

















 5.14 Assumptions  
 
- The mortality rates in both treatment groups are the same  
- No other comorbidity that will result in additional hospital stay  
- Patients come to hospital immediately after injury without prior visit to a traditional healer 
- Patients have no previous history of femoral bone fracture 
- Patients with malunion/non-union/delayed union – would manifest problems mentioned in 












       
 
 





6.  Results  
6.1  Cost   
6.1.1 Direct out of pocket expenditure for Traction Treatment Group  
The total out of pocket expenditure for all patients in this treatment group was 6,262 USD 
(132,754 ETB) with cost per patient being 250 USD (5,310 ETB)  95 %CI  of (200 , 300) (see 
Table 2).  The main cost drivers were cost of food and hospital bed which contributed 47 % and 
23 % respectively. In this treatment group, the mean hospital stay was 53 days.     
 
Table 2: Direct out of pocket expenditure per service type for the traction treatment group  
 Total (USD) Mean (USD) SD (USD) 95 % CI 
Card  25.5 1 0.4 (0.9 - 1.2) 
Hospital Bed  1,464 58 24 (48.8 - 68.3) 
Drug  469 18 3 (17.8 - 19.7) 
Physiotherapy  679 27 0  
X ray  62 2  0.9 (2.1 - 2.8) 
Lab  16.4 0.7 0.9 (0.3 - 1) 
Food  3001 120 95 (82.8 - 157.3) 
Attendant 527 21 54  (0.3 - 42.5) 
Total  
 




6.1.2 Direct out of pocket expenditure for IMN treatment group   
The total direct out of pocket expenditure for all patients in this treatment group was 4,849 USD 
(102,804 ETB) with cost per patient being 194 USD (4112 ETB) and 95% CI of (154.3, 233.6) 
(see Table 3).  The main cost drivers were food and hospital bed which constituted of 48 % and 





Table 3: Direct out of pocket expenditure per service type for the IMN treatment group  
 Total Mean SD 95 % CI 
Card  22 USD 0.9 USD 0.3 (0.8 - 0.9) 
Hospital Bed  909 USD 36.4 USD 30.1 (24.6 - 48.2) 
Drug  553 USD 22.1 USD 13.5 (16.8 - 27.4) 
Physiotherapy  452 USD 18.1 USD 0 (18.1 - 18.1) 
X ray  63 USD 2.5 USD 0.6 (2.3 - 2.8) 
Lab  78 USD 3.2 USD 2.6 (2.1 - 4.2) 
Food  2359 USD 94.4 USD 63.5 (69.5 - 119.3) 
Attendant  294 USD 11.8 USD 36.6 (2.5 - 26.1) 
Total  4,849 USD 194 USD 101 (154.3 - 233.6) 
 
 
6.1.3 Provider Cost for Traction and IMN treatment group  
The total provider cost for traction treatment group was 1562 USD (33,122 ETB) and the 
provider cost per treated patient was 62 USD (1324 ETB). The total provider cost for IMN 
treatment group was 6,111 USD (129,566 ETB) and the provider cost per treated patient was 244 
USD (5182 ETB).    
 
Table 4: Provider Cost for the two treatment groups    
Traction  
  Total Mean SD 95 % CI 
Medical equipment 
and Consumables 
565 USD 22 USD 0  
Salary 997 USD 39 USD 0  




5,308 USD 212 USD 0  




Total  6,111 USD 244 USD 0  
 
6.1.4 Total Cost for Traction and IMN treatment group  
The total cost for traction treatment group was 7, 824 USD (165,869 ETB) and the cost per 
patient was 313 USD (6,636 ETB). The total cost for the IMN group was 10,961 USD (232,373 
ETB).   
 
Table 5: Total cost for Traction and IMN treatment  
 Total Cost 
(USD)  
Cost per Patient 
(USD)   
SD  95 % CI  
Traction 7,824 313 128.6  (262.6 -363.4) 
IMN  
	






The total discounted HALY in traction group after treatment was 411. The mean was 16.4 with 
95 % CI of (16.1, 16.8). The net discounted HALY in this treatment group was 16.2 and the net 































P1 22.9 22.9 0 15.8 15.8 0 
P2 22.9 22.9 0 15.8 15.8 0 
P3 27.9 22.9 5 15.8 18.1 2.3 
P4 22.9 22.9 0 15.8 15.8 0 
P5 25.9 22.9 3 15.8 17.2 1.4 
P6 25.9 22.9 3 15.8 17.2 1.4 
P7 22.9 22.9 0 15.8 15.8 0 
P8 25.9 22.9 3 15.8 17.2 1.4 
P9 25.9 22.9 3 15.8 17.2 1.4 
P10 25.9 22.9 3 15.8 17.2 1.4 
P11 22.9 22.9 0 15.8 15.8 0 
P12 27.9 22.9 5 15.8 18.1 2.3 
P13 25.9 22.9 3 15.8 17.2 1.4 
P14 22.9 22.9 0 15.8 15.8 0 
P15 22.9 22.9 0 15.8 15.8 0 
P16 22.9 22.9 0 15.8 15.8 0 
P17 22.9 22.9 0 15.8 15.8 0 
P18 22.9 22.9 0 15.8 15.8 0 
P44 22.9 22.9 0 15.8 15.8 0 
P45 22.9 22.9 0 15.8 15.8 0 
P46 22.9 22.9 0 15.8 15.8 0 









The total discounted HALY in IMN group after treatment was 428.3. The mean was 17.1 with 95 
% CI of (16.9,17.4).  The net discounted HALY in this treatment group was 33.6 and the net 
undiscounted HALY was 70 (Table 7).  
 
 Table 7: Health Adjusted Life Years ( HALYs) gained in IMN treatment group. 
P48 25.9 22.9 3 15.8 17.2 1.4 
P49 22.9 22.9 0 15.8 15.8 0 
P50 25.9 22.9 3 15.8 17.2 1.4 
HALY 
Gain 



















P19 22.9 22.9 0 15.8 15.8 0 
P20 25.9 22.9 3 15.8 17.2 1.4 
P21 25.9 22.9 3 15.8 17.2 1.4 
P22 25.9 22.9 3 15.8 17.2 1.4 
P23 25.9 22.9 3 15.8 17.2 1.4 
P24 22.9 22.9 0 15.8 15.8 0 
P25 25.9 22.9 3 15.8 17.2 1.4 
P26 22.9 22.9 0 15.8 15.8 0 
P27 25.9 22.9 3 15.8 17.2 1.4 
P28 25.9 22.9 3 15.8 17.2 1.4 










The average cost-effectiveness ratio (ACER) for both treatment groups has been calculated by 
dividing the total cost to the net discounted HALY gained in each intervention group. This gives 
483 USD per HALY gained in the traction group and 326 USD per HALY gained for IMN 
treatment group (Table 8). The incremental cost of going from traction to IMN is 3137 USD and 
the incremental health gain of going from traction to IMN group is 17 HALYs.  The ICER is 180 
USD per HALY gained.  
 
Table 8 : Average and Incremental Cost-Effectiveness Ratio     
P30 25.9 22.9 3 15.8 17.2 1.4 
P31 27.9 22.9 5 15.8 18.1 2.3 
P32 25.9 22.9 3 15.8 17.2 1.4 
P33 25.9 22.9 3 15.8 17.2 1.4 
P34 25.9 22.9 3 15.8 17.2 1.4 
P35 25.9 22.9 3 15.8 17.2 1.4 
P36 27.9 22.9 5 15.8 18.1 2.3 
P37 25.9 22.9 3 15.8 17.2 1.4 
P38 25.9 22.9 3 15.8 17.2 1.4 
P39 25.9 22.9 3 15.8 17.2 1.4 
P40 25.9 22.9 3 15.8 17.2 1.4 
P41 25.9 22.9 3 15.8 17.2 1.4 
P42 25.9 22.9 3 15.8 17.2 1.4 
P43 25.9 22.9 3 15.8 17.2 1.4 
HALY 
gain 
























16.2	 483	 	 	 	
IMN		 10,961		
	
33.6		 326	 3137	 17	 180		
	 	
 
For undiscounted HALYs, the ACER would be 157 USD/HALY for IMN and 230 USD/HALY 
for traction treatment and the ICER would be 87 USD/HALY gained.   
 
7. Discussion  
The total cost of treatment was 7,824 USD and 10,961 USD in traction and IMN treatment group 
respectively. The net discounted HALY gained in traction treatment group was 16.2 and it was 
33.6 in the IMN group. The ACER was 483 USD/HALY gained for the traction treatment group 
and it was 326 USD/HALY gained in the IMN treatment group. The ICER was 180 USD/HALY 
gained.  
As it has been stated on the result part, the sum of the net discounted HALY (33.6) in IMN 
treatment group is greater than that of in traction treatment group (16.2). The difference in the 
sum of net discounted HALY between the two groups could have been larger. One major reason 
for the small difference between the two groups could be that patients in the two groups are 
interviewed in different post discharge period, i.e. the mean time of interview for traction 
treatment group was 11.6 months after the time of injury with 95 CI of (8.48, 14.7) and the mean 
time of interview for IMN treatment group was 4 months with 95 % confidence interval of (2.7, 
5.3). The effectiveness may therefore have been underestimated. 
Regarding cost of treatment, the perspective that is taken is societal perspective. Health provider 
cost like professional’s salary, equipment and consumables cost was also included.  
Transportation accounted for 22.27 % of the total treatment cost in traction treatment group and 
42.3 % in IMN treatment group. The reason for this difference is that more patients in the IMN 




Oromia region. For this reason the transportation cost has not been taken as part of the total cost 
for the treatment groups. The total costs for the IMN treatment group may therefore have been 
underestimated.   
  
The total cost incurred for the treatment of patients in the IMN group was greater than the total 
cost incurred for patients in traction group. This difference was mainly due to the higher provider 
cost incurred in IMN group which in turn was mainly due to the cost of medical equipment and 
consumables that constituted 48 % of the total cost.  However with regards to health gains 
patients in IMN treatment group have gained more HALY, the result which could have been 
higher if the time of interview was optimal as stated above. There for by calculating the ACER, 
it has been shown that IMN was cost effective in the treatment of femur fracture than traction, i.e 
326 USD was incurred to gain a unit of HALY in the IMN treatment group compared to 483 
USD for a unit of HALY in traction treatment group.   
 
A study done in Thika level 5 hospital in Kenya has shown findings that fit well with our study. 
The study has taken exclusively the direct out of pocket expenditure for ward bed and drugs and 
the result was - mean cost of treatment for patients who underwent IMN was 112 USD compared 
to those managed by skeletal traction 156 USD(12). Similarly, if we compare only the direct out 
of pocket expenditure between the two treatment groups in our study, the mean cost of the 
traction treatment group was higher (250 USD) than the mean cost in the IMN treatment group 
(194 USD).  
Another study done in Kenyatta National Hospital, located in Nairobi Kenya, has shown that 
Intramedullary nailing was more cost-effective than skeletal traction for the treatment of patients 
with femur fracture. In this study, the average total hospital cost for the operative group was 640 
USD compared to 798 USD for the traction group. In the operative group 24 patients had union 
with one delayed union while in the traction group 12 patients had union, 9 with mal union and 4 
delayed union. (23) 





8. Limitation of the study  
There are some limitations in this study. The first one is that the scoring system that was used to 
measure HALY gained is not externally validated. Second, study participants in the two 
treatment groups were interviewed in different timing post discharge which in turn can affect the 
effectiveness measure. Third, the comparison groups were not randomized to each type of 
treatment. We could not therefore exclude selection bias. Finally, this study has not considered 
all parts of provider costs, but mainly fixed costs, which can limit our ability to perform 
comparisons of the result of this study with other similar studies.    
 
9. Conclusion  
This study showed that IMN was more cost effective than traction for the treatment of patients 
with femur fracture. Transportation accounted for 22.3 % of the total treatment cost in traction 
treatment group and 42.3 % in IMN treatment group. Thus, we recommend that follow up clinics 
are established in primary level hospitals in regions outside Addis so that patients would incur 


























































































   
  
Annex	2	:	Price	list	of	Drug,	laboratory	,	imaging	and	hospital	bed		
2.1  Drug Price List  
 Minilik Hospital 
(Birr per vial) 
 
AaBET Hospital 
( ETB per 
vial/tab/unit)  
Average 
( ETB per 
vial/tab/unit)  
Ceftriaxone  8.9 per vial 16 Birr  12.5  
Metronidazole 7.1  13  10  
Cloxacillin, PO 1.2  1  1.1  
Ciprofloxacillin  0.9  Was not given 0.9  
Tramadol, Vial Was not given 8  8  
Tramadol, Tab  0.8  1.4  1.1  
Diclofenac, Vial  1.7  2.5  2.1  
Diclofenac, PO  0.1  0.2  0.1  
Augmentin 2.8  
 
17.5  10.4  
Diazepam  Not given 0.6  0.6  
Vancomycin  Not given 130.8  130.8  
NS, 1000 ml 24.9  25  24.9  
DNS 26.5  26.5  26.5  
RL  26  26.5 26.2  
Amoxicillin   0.9  0.9  0.9  
Musculoskeletal Prrelevantoblem (GBD 2013) 
Mild  0.023 (0.013 - 0.037) 
Moderate  0.079 (0.054 – 0.11) 




Cloxacillin, vial  2.5  3  2.8  
Paracetamol  0.2  0.2  0.2  
Pethidine  Was not given 17.5  17.5  
Surgical Glove  
 
Not given 6  6  
Syringe  
5 cc 






































( In ETB)  
AaBET 
( In ETB) 
Average 
( In ETB)  
Fem x ray  20  10 15  
Chest x ray 20  5  12  
CBC  35 20  27  
LFT  
 
SGOT -10  
SGPT -10  
20  
SGOT -5  





Urea -10  
Creatinine -10   
20.00  
Urea - 5  




















Hospital Bed/day  1st Class, 60  2.5  31.3  
 2nd Class, 40  2.5  21.3  
 3rd Class,20  2.50  11.3  
Physiotherapy 
Sessions  
20/session 12/session 16/ session  
 
2.4 Fixed Cost  




Quantity Cost per Unit 
( In ETB)  
  Total Cost for Item 
            ( In ETB)  
Intramedullary nail 1 3450 3450 
Surgical Blade 4 30 120 
Vicryl, no 1, round 4 50 200 
Vicryl, no 2, cutting  3 72.5 217.4 
Roll Bandage  5 5 25 
Gauze  40 7.4 294 
Abdominal Pack  5 20 100 
Zinc Plaster  1 25 25 
OFT  LFT + RFT  30  
BG/Rh  5  5  5  
AFB 5  2.8  3.8   
ESR  5  0.8  2.8  




Iodine  1 20 20 
Alcohol  1 50 50 
Sum    4501.4   
 
2.4.2 Equipment and consumable cost for a patient treated by traction  
 
Equipment/supply  Quantity Cost per unit  
( In ETB) 
Total cost for Item  
             ( In ETB)  
Pin  1 300 300 
Drill  1 100 100 
Alcohol  1 50 50 
Gauze  4 7.4 29.4 
Sum   457.4 479.4 
 
3.Health	Professionals’	salary		




















( In ETB)  
 
Working hrs per 
month 
 
ETB per hour  
1. Senior Medical 
Specialist 







































               
 
 







Activity -  Initial  
Evaluation (history 
taking, physical 
examination)   
Time Spent – 25 
Min 
Activity - Major round 
Time spent - 15 min (for 




2 days/week, 16 days  
16 days * 15 min = 240 min= 4 hrs  
Round  
2 days/week, 10 days  
10 days * 15 min = 150 min= 2.5 hrs  
Follow Up (For GP)  
2 days/week, 16 days  
16 days * 20 min = 320 min = 5.3 hrs 
Follow Up  
2 days/week, 10 days  
10 days * 20 min = 200min = 3.3 hrs  
Pin Site Care  
3 days per week (every other day), 24 days  
24 days * 5 min = 120 min, 2 hrs  
Wound site care  
3 days/week, 15 days  
15 days * 10 min = 150 min= 2.5 hrs   
Vital Sign Taking  
Every day, 56 days  
56 days * 5 min = 280 min = 4.7 hrs  
Vital Sign Taking  
7 day/week, 35 days  




Activity – Do 
skeletal traction  




Activity - Follow up for 
pain assessment/ call based 
consultation   








Activity –Major Round  





Activity -  Initial  
Assessment and  
Nursing care 
Evaluation 
Time Spent – 25 
Min   
Activity - Major  round  
Time Spent -15 min per 
patient   
Activity - Pin site Care  
Time Spent – 5 min   
Activity - Taking  Vital 
Sign  
Time Spent -   5 min per 
day 
Activity - Assist in 
skeletal traction  
Time Spent - 40 
min  
 
                                        














Total Time at 
EOPD/patient  – 
1.08 hr  
 
 Total time for 










Total time for call 
based 
consultation/patient- 











 Total time for 
round/patient – 4 hrs  
 
4 hrs  60.23 
Birr/hr * 







Total Time at 
EOPD/patient  – 
1.08 hr  
 
 Total time for 
round/patient – 4 hrs  
 





Total time for pin 
site care/patient – 2 
hrs  
 
Total time for taking 
vital sign/patient – 
4.7 hrs   
 


















Activity -  Initial 
Evaluation (history 
taking, physical 
examination)   




Activity – IMN 
insertion  
Time Spent – 1 hr  
 
 
Activity - Major 
round 
Time spent - 15 min 
(for one patient)  
Activity - Follow up 
for pain assessment/ 
call based consultation  










Activity – IMN 
insertion  
Time Spent – 1 hr 
Activity –Major 
Round  






Activity -  Initial  
Assessment and  
Nursing care 
Evaluation 
Time Spent – 25 
Min    
Activity – IMN 
insertion  
Time Spent – 1 hr 
Activity - Major  
round  
Time Spent -15 min 
per patient   
Activity – Wound 
Care  
Time Spent –  10 min  
Activity - Taking  
Vital Sign  





 Anesthesist  
 
 Activity – IMN 
insertion  
Time Spent – 1 hr 
 
       











Total Time at 
EOPD/patient  – 






– 1 hr  
 
Total time for 
round/patient – 2.5 
hrs  
 
7.2 hrs  32.4 
Birr/hr * 
7.2 = 
233.9 Birr  
 Total time for call 
based 
consultation/patien












– 1 hr  
Total time for 
round/patient – 2.5 
hrs  
 
 3.5 hrs  60.2 
Birr/hr * 
3.5 hrs = 








Anesthesist   Total time 
at 
OR/patient 
– 1 hr  
 
 1 hr  22.7 
Birr/hr * 
1 = 22.7 




Total Time at 
EOPD/patient  – 





– 1 hr  
 
Total time for 
round/patient – 2.5 
hrs  
 
9.3 hrs  22.7 
Birr/hr* 
9.3 hrs = 
211.6 Birr  
Total time for 
wound care/patient 
– 2.5 hrs   
 
Total time for 
taking vital 
sign/patient – 2.9 
hrs    
 












Out Patient care expenditure   
Age of the patient -  
1) After discharge from hospital: 
- How many times did you come for an appointment/follow up at the hospital 
- How many times did you come to the hospital for additional visit other than your 
appointment/follow up date (e.g. for complication) 
- How many days/months have you been away from work due to the fracture?  
 
2) How much did you spend in total for a follow up visit  
                                Total expenditure:____________________________ 
                                Drugs: __________________________________________ 
         Laboratory:  
         Imaging:_______________________________ 
         For Card/Consultation fee     
         Transportation to and from health facility:______________ 
         Additional expenses for care giver_____________________ 
         Accommodation (for patients coming outside Addis Ababa)  
         Food (for patients coming outside Addis Ababa) 
         Traditional healer:__________________________________ 
         Others (describe)__________________________________ 
In	patient	care	expenditure		
  
1) How many days were you admitted at the hospital? 
2) How much did you spend in total on the below items during your hospitalization? 
 
Total expenditure:_________________________________ 





iii. Image  
iv. Laboratory _______________________________ 
v. Food___________________________________________ 
vi. Transportation to and from the hospital______________ 






1. Did you have pain on the fractured leg after treatment?  
    a. Yes  
    b. No  
If your answer for question no 1 was Yes, please answer the following questions. 
2. Does the pain cause problem in running? 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time  
3. Does the pain cause difficulty in getting up and down? 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
4. Does the pain make you limp? 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
5. Does the pain cause some difficulty in walking? 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
6. Does the pain cause some difficulty in standing 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
7. Does the pain cause difficulty in lifting heavy things  
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
8. Does the pain cause difficulty in carrying heavy things 
      a. Sometimes              b. Occurs more often          c. Occurs almost every time 
9. Does the pain cause difficulty in sleeping  

























Medical Record No  
 
Date of Admission  Address  




Type of Imaging Done  (Including Number of times) 
 
 
Type of Laboratory Done (Including number of times)  
 
 













7.1  Ethical Clearance  
Ethical clearance has been obtained from the Western Regional Ethical Committee in Norway, 
Addis Ababa Regional Health Bureau and from St Paul Millennium Medical College. 
Written informed consent has been obtained from the study participants. Study participants have 
been told that their participation is voluntary and they have the right to withdraw from the study 
at any time. The data material obtained from participants has been given a code and stored in a 
laptop.  
7.2  Informed Consent   
      Hello, my name is…………… and I am working in a research project on Cost Effective 
Analysis of Femur fracture Treatment in Ethiopia.  
       Femur bone fracture is one of the most common types of fracture in Ethiopia secondary to 
road traffic accident and other type of injury. And many injured patients come to seek medical 
care to facilities like Tikur Anbessa Specialized Hospital. There are two main treatment options 
for this clinical condition i.e. conservative and surgery. These two treatment options have 
varying effectiveness and associated cost. This study aims to find out which of the two treatment 
options can give better clinical outcome with a low cost of care.       
  
       A structured questionnaire will be used to ask you questions. The expected duration of the 
interview will be 15- 20 minutes. If you have any question, please ask me to stop and I will take 
time to explain.      
     Your participation in this study is voluntary. You do not have to take part in this research if 
you do not wish to do so and refusing to participate will not affect your treatment at this hospital 
in any way. There are no known negative effects by participating on this study and there are no 
direct advantages for you personally either.  
       The information that we collect from this research project will be kept confidential. 
Information about you that will be collected during the research will be given a code rather than 




      If you decide to participate, kindly give your written consent before the interview.  If you 
wish to withdraw your consent after the interview ended or have questions concerning the study 
you may contact Feven Girma, principal investigator with her number + 251 911098464. 
 
7.3  Certificate of consent  
      I have read the foregoing information or it has been read to me. I have had the opportunity to 
ask questions about it and any question that I have asked have been answered to my satisfaction. 
I consent voluntarily to participate in this research.  
 
Name of participant  
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